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  arginase-mediated urea synthesis from arginine (Egan et al., 1995). 
Intravenous infusion of lysine resulted in a significant increase in 
plasma levels of arginine (Kato et al., 1987), suggesting increased 
availability of arginine for NO synthesis. In general, lysine signal-
ing might play a number of important physiological functions. In 
fact, inhibition of atherosclerosis formation (Yamori et al., 1978) 
and cellular proliferation properties (Datta et al., 2000) has been 
reported. Furthermore, lysine-enriched experimental foods sup-
press stress-induced anxiety in rats and humans (Smriga and Torii, 
2003a; Smriga et al., 2004), an effect that was further enhanced 
by combination with arginine (Smriga and Torii, 2003b; Smriga 
et al., 2007). Voluntary ingestion of lysine in drinking water tends 
to reduce the incidence of stroke in stroke-prone spontaneously 
hypertensive rats (Yamori et al., 1977). To date, however, effects of 
lysine alone, or combination of lysine and arginine, on cerebral 
ischemic damages have not been investigated.
The role of the acidic amino acids, glutamate and aspartate, 
as excitatory neurotransmitters in the brain is well documented 
(Johnson, 1978). Compared to other amino acids, the   concentrations 
IntroductIon
l-Arginine, a basic amino acid, is a precursor of nitric oxide (NO) 
that  displays  potent  vascular  relaxant  properties.  Intravenous 
administration of arginine (Morikawa et al., 1992, 1994) or NO 
donors (Zhang and Iadecola, 1994) have been shown to reduce 
ischemic infarction, while administration of NO synthase (NOS) 
inhibitors exacerbates brain damage (Kuluz et al., 1993). However, 
it must be noted that different lines of evidence suggesting that 
arginine exacerbates (Zhao et al. 2003) and NOS inhibitors amel-
iorate (Buisson et al., 1992; Kozniewska et al., 1995; Quast et al., 
1995) ischemic infarction have also been reported.
In any event, arginine does not seem to be the only basic amino 
acid involved in neuroprotection against brain injury. Ebenezar 
et al. (2003) reported the protective effects of arginine and lysine 
combinations  against  experimentally  induced  myocardial  inf-
arction  in  rats. While  sharing  many  common  properties  with 
L-arginine, l-lysine is a basic amino acid that does not function 
as a substrate for NO synthesis (Smulders et al., 1997). In addi-
tion, lysine is a potent inhibitor of arginase and hence blocks 
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neuroprotective effects.
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of these acidic amino acids are consistently low in both circulation 
and cerebrospinal fluids, whereas concentrations of basic amino 
acids (lysine and arginine) are high (Nishimura et al., 1995). This 
phenomenon might result from the presence of high-affinity carrier 
systems for basic amino acids, resulting in high uptake of lysine 
and arginine into the brain (Oldendorf and Szabo, 1976). In any 
case, the physiological function of such high levels of basic amino 
acids in the brain remains unclear.
It is noticeable that, during ischemia/reperfusion, high levels of 
glutamate release followed by calcium overload and abnormal pro-
duction of free radicals occurs (Won et al., 2002). The N-methyl-d-
aspartate (NMDA) receptor, the major type of excitatory glutamate 
receptor, comprises ligand-gated cation selective channel whose 
activity is blocked by divalent cation Mg2+ and Zn2+ (Mayer et al., 
1984; Nowak et al., 1984). Accordingly, we have hypothesized that 
basic (and hence cationic) amino acids might suppress glutamate-
induced neuronal activation and prevent neuronal death in the 
brain. If this hypothesis is confirmed, oral administration of basic 
amino acids may be effective to suppress ischemic insults. To our 
knowledge, there is no available evidence on the effects of basic 
amino acids on neuronal activity in vivo.
The present study aimed at investigating the neuroprotective 
effects of lysine, arginine, and their combination during the acute 
phase (2 days after the ischemia/reperfusion) of cerebral edema 
formation, hemispheric brain swelling and infarction as revealed by 
magnetic resonance imaging (MRI) and 2,3,5-triphenyltetrazolium 
chloride (TTC) histological staining in rats. Because cerebral edema 
generally accompanies with brain swelling and resulting in excessive 
intracranial pressure, finding ways to prevent cerebral edema has 
been a major research endeavor for reducing mortality or delayed 
neural injury after ischemia. We also examined the influence of 
microiontophoretically  (juxtaneuronally)  applied  basic  amino 
acids on glutamate-induced single unit activity in the ventrome-
dial nucleus of the hypothalamus (VMH) neurons of awake rats. 
We undertook this study in conscious rats, as opposed to previous 
studies where the interactions between glutamate and test com-
pounds were restricted to cultured neurons (Mayer et al., 1984; 
Nowak et al., 1984). The results of the present study suggest that 
the ingestion of some specific classes of amino acids may result in 
beneficial neuroprotective effects.
MaterIals and Methods
We tested two main hypotheses, namely, both reduction of cerebral 
ischemic insults and inhibition of glutamate-induced neuronal 
activity by lysine and arginine administration in rats.
anIMals
In the ischemia experiments, 64 male Wistar rats (Charles River 
Laboratories Japan, Yokohama, Japan), weighing 280–320 g, were 
randomly assigned to five groups: saline group (control, n = 12), 
0.6 g/kg lysine group (n = 14), 2.0 g/kg lysine group (n = 13), 0.6 g/
kg arginine group (n = 11), and combination of 0.6 g/kg lysine 
and 0.6 g/kg arginine group (n = 14). In the neuronal recording 
experiments, eight male Wistar rats, weighing 300–500 g, were used. 
Each rat was housed individually in a wire-meshed cage with free 
access to laboratory chow (CRF-1; Oriental Yeast, Tokyo, Japan) 
and tap water in a room where temperature (23 ± 1°C), relative 
humidity (50 ± 10%), and light (07:00–19:00) were controlled. All 
experiments were approved by the local committee on Ethics for 
Animal Experimentation and were carried out in accordance with 
the National Institute of Health Guide for the Care and Use of 
Laboratory Animals and with guiding principles for the Care and 
Use of Animals in the Field of Physiological Sciences recommended 
by the Physiological Society of Japan. All necessary actions were 
undertaken to minimize animal suffering and reduce the number 
of animals used.
surgery for cerebral IscheMIa
After overnight fasting, rats were subjected to 1 h of middle cerebral 
artery (MCA) occlusion (MCAO) followed by reperfusion, a model 
of focal ischemia resembling that of human stroke (Belayev et al. 
1996). The ischemic surgery (intraluminal occlusion technique) 
was as reported earlier (Kondoh et al., 2002; Torii et al., 2004). 
Briefly, rats were anesthetized with 1.5% halothane in a mixture 
of 30%O2/70%N2O gas and maintained the rectal temperature at 
37°C by a heating pad. An artificial embolus (a 4-0 Ethicon nylon 
filament with tip diameter tapered to the size of 25 or 24-gauge 
needle) was inserted from external carotid artery, via the internal 
carotid artery, to the base of either the left or right MCA to stop 
blood flow to the MCA. During ischemia, anesthesia was inter-
rupted and rats were allowed to recover for 1 h and behavioral 
tests (see below) were performed to confirm successful unilateral 
ischemia. After 1 h of ischemia, the rats were re-anesthetized with 
halothane, the embolus withdrawn, the blood reperfusion estab-
lished, and the skin sutured. After surgery, an antibiotic (gentami-
cine sulfate, Gentacin® Injection, Schering-Plough, Osaka, Japan) 
was administered systematically (8 mU, i.m.).
surgerIes for neuronal recordIng
Prior to the cranioplastic surgery, rats were acclimated by handling 
and accustomed to being placed into a small restraining cage that 
was constructed with stainless steel rods.
For  neuronal  recording  in  the  VMH,  clanioplastic  surgery 
and skull opening surgery were performed on the separate days 
as described earlier (Tamura et al., 2000). Twenty minutes after 
an injection of atropine (0.1 mg/kg, i.p.), each rat was anesthe-
tized with pentobarbital sodium (50 mg/kg, i.p.), and mounted 
on a stereotaxic apparatus with the skull inclination aligned to the 
bregma – lambda suture points. The cranium was exposed and five 
stainless steel screws (2-mm diameter) were threaded into holes 
in the skull to serve as anchors for cranioplastic acrylic. Stainless 
steel wires were soldered onto two screws to serve as ground. The 
cranioplastic acrylic was built up on the skull and molded around 
the conical ends of two sets of double stainless steel rods (fake 
ear bars) which had a single steel bar on one end and two bars 
on the other end. Once the cement had hardened, these bars were 
removed, leaving impression indentations on the double end on 
each side of the acrylic block. During subsequent surgery, training 
sessions, and recording sessions, the double end of these fake ear 
bars was pressed into the indentations in the acrylic block while 
the single end was inserted into the normal ear bar slot in the 
stereotaxic apparatus and rigidly attached to it. Hence, these fake 
ear bars functioned as regular ear bars but could also be used in 
awake animals because they did not involve painful insertion into Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 18  |  3
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ear canals. A short length of stainless steel tubing (27-gauge) was 
embedded in the cranioplastic acrylic near bregma to serve as a 
reference coordinate pin during chronic recording. After surgery, 
the antibiotic (gentamicine sulfate) was administered topically and 
systematically (8 mU, i.m.).
After  recovery  (7–10  days)  from  the  cranioplastic  surgery 
mentioned above and following recording training (2 weeks; see 
next section), the rats were reanesthetized (pentobarbital sodium, 
40 mg/kg, i.p.) and mounted in the stereotaxic apparatus using the 
fake ear bars. A hole (2- to 3-mm diameter) for chronic record-
ing was drilled through the cranioplastic cap and underlying skull 
located over the intended recording site of the VMH (A, −2.3 to −3.3 
from bregma; L, 0.3–1.0; V, 8.0–10.0). The exposed dura matter was 
covered with hydrocortisone ointment (Rinderon-VG® ointment, 
Shionogi, Osaka, Japan). The hole was covered with sterile cotton 
and sealed with epoxy glue.
traInIng for neuronal recordIng
Following recovery from the cranioplastic surgery, the rats were 
placed on a 20- to 23-h water-deprivation regimen for training of 
neuronal recording. Each rat was placed in a restraining cage with 
the head fixed rigidly and painlessly in the stereotaxic apparatus 
by the fake ear bars. While restrained, rats had access to a spout 
from which they learned to take water. Rats were trained during 
increasingly longer periods, initially 1 h to eventually 4 h per day. 
After an adaptation period, most rats accepted the restraint for up 
to 4 h without manifesting distress. Throughout the training and 
recording periods, the rat was allowed to ingest 20 ml of fluid per 
session in the restraining cage. If a rat failed to take a total volume 
of 20-ml fluid in the training, tap water was given when the rat 
was returned to its home cage so that the final volume of total 
intake was 20 ml.
aMIno acId adMInIstratIon
In the ischemia experiments, l-lysine HCl and l-arginine HCl 
(Ajinomoto, Tokyo, Japan) were dissolved in saline. The pH was 
5.59–5.65 for lysine HCl solution, 5.66 for arginine HCl solution, 
and 5.59 for the mixture solution of lysine and arginine. They were 
administered twice orally (5 ml/kg for twice): just 30 min before 
MCAO and 10 min before reperfusion. Each administration was 
comprised of half of the final dose. Physiological saline (0.15 M 
NaCl, pH was not adjusted) was administered similarly to the con-
trol group.
behavIoral test
To assess whether the ischemia procedure was successful, the fore-
limb akinesia and the spontaneous rotational tests were performed 
during MCAO (i.e., during 1-h embolism). Detailed description 
and specific criteria for each test have been reported elsewhere 
(Borlongan et al., 2000; Torii et al., 2004). Briefly, the forelimb 
akinesia test involved tail suspension of the animal observation 
of the positions of the forelimbs. Rats with MCAO demonstrate a 
characteristic forelimb posture: it is stretched out on the ischemic 
side while in the contralateral side it is clipped to their chest mus-
cles. For the spontaneous rotational test, the rat was placed in a 
box made of Plexiglas and the direction of the rat’s rotation was 
observed during a 5-min session.
MagnetIc resonance IMagIng (MrI)
The  T2-weighted  brain  images  of  ischemic  rats  were  acquired 
using an MRI system (SMIS, Guilford, UK) consisted of a 4.7 
T/400 horizontal superconducting magnet equipped with actively 
shielded  gradient  coils  (73  mT/m,  26  cm  of  free  inner  diam-
eter). We measured ischemic edema only at 2 days following the 
ischemic surgery because maximal cerebral water content (cer-
ebral edema) is measured at 1–2 days after MCAO, after which the 
edema attenuates gradually (Hatashita et al., 1988; Toung et al., 
2002). Rats were anesthetized with 1.5% isoflurane in a mixture of 
30%O2/70%N2O gas. Body temperature was controlled at 37°C by 
circulating water. Their heads were fixed firmly in a non-magnetic 
stereotaxic apparatus specially designed for MRI. A home-made 
volume coil (60-mm diameter) was used for both transmission 
and  reception  of  radio  frequency  wave.  For  the  evaluation  of 
cerebral edema volume and hemispheric brain swelling, 15 con-
secutive coronal brain images were acquired using conventional 
T2-weighted multi-slice spin-echo pulse sequence. The param-
eters were: time of repetition = 6,000 ms, echo time = 80 ms, field 
of view = 38.4 mm × 38.4 mm, matrix = 128 × 128, slice thick-
ness = 1.2 mm, number of slices = 15 with no gap, slice inter-
leave = 4, no average.
For generating T2 maps, the coronal plane at the level of bregma, 
in which the extent of edema was the greatest (Torii et al., 2004), 
was excited using multi-echo spin-echo pulse sequence. The param-
eters were: time of repetition = 2,500 ms, basal echo time = 20 
ms, echo train length = 6, field of view = 38.4 mm × 38.4 mm, 
matrix = 128 × 128, slice thickness = 2.0 mm, no average.
2,3,5-trIphenyltetrazolIuM chlorIde (ttc) staInIng
After the completion of the MRI experiments, rats were anesthe-
tized with pentobarbital sodium (50 mg/kg, i.p.) and sacrificed 
by cervical dislocation. The brain was quickly removed for TTC 
(Sigma-Aldrich, St. Louis, MO, USA) histological staining. Coronal 
brain slices of 1 mm were obtained by a brain slicer (VT1000S, 
Leica, Wetzlar, Germany) and incubated in 2% TTC dissolved in 
0.1 M phosphate-buffered saline at 37°C for 30 min and then fixed 
by immersion in 10% phosphate-buffered formalin as reported 
by Bederson et al. (1986). Photographs of coronal sections were 
taken with a digital camera (COOLPIX950, Nikon, Tokyo, Japan). 
The  unstained  areas  of  the  fixed  brain  sections  were  defined 
as infarcted.
neuronal recordIng and in vivo MIcroIontophoresIs
Extracellular single unit activities were recorded from the VMH 
of awake rats. Although spontaneous firing rates of VMH neu-
rons in awake rats are very low (Tamura et al., 2000), our pilot 
experiments suggested the presence of many silent neurons in 
VMH, whose activities could be evoked by microiontophoretic 
application of glutamate on the neuronal membrane recorded. The 
method of microiontophoresis is well established for investigat-
ing effects of various bioactive substances on recorded neurons 
in the brain (Curtis and Koizumi, 1961). With this technique, 
charged molecules or ions can be ejected without negligible injury. 
This approach has a merit of bypassing the major diffusion bar-
riers and of limiting the potential site of chemical action to the 
recorded neuron.Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 18  |  4
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calculatIon of InfarctIon area
The digital photographs of the coronal sections (color images) were 
converted to grayscale images and smoothed by a Gaussian filter 
with full-width at half maximum of 2.0 pixels. Infarct areas within 
each slice were extracted with a low cut filter, number of pixels was 
counted, and then calibrated. Total infarct area was calculated as 
the sum of infarct areas in each slice.
statIstIcal analysIs
Statistical comparisons between saline-treated control groups and 
amino acid-treated groups were made using one-way anova 
followed by Fisher’s protected least significant difference (PLSD) 
test. Differences were considered significant at p < 0.05. Results are 
expressed as means ± SEM.
hIstology
After the last recording session, each rat was anesthetized with 
pentobarbital sodium (50 mg/kg, i.p.). Several iron deposits were 
made stereotaxically around the recorded sites in the brain by pass-
ing positive current (20 μA, 30 s) through a stainless steel electrode 
(0.2-mm diameter, polyurethane insulated except for 0.1 mm at 
the tip). Rats were then given a further overdose of anesthetic and 
perfused transcardially with heparinized 0.9% saline followed by 
10% buffered formalin containing 2% potassium ferrocyanide. 
The brain was removed, and cut into 50-μm coronal sections 
with a freezing microtome. Sections were stained with cresyl vio-
let. All marking sites were verified microscopically. The location 
of each recording site was then calculated from the stereotaxic 
coordinates of the recording electrode and the coordinates of the 
marking electrodes.
results
suppressIon of cerebral edeMa
Volume of cerebral edema in anesthetized rats was measured by using 
high resolution MRI. Figure 1 shows five consecutive T2-weighted 
images in rats treated with 0.9% saline (control) or 2.0 g/kg lysine. 
Increases in signal intensities (corresponding to cerebral edema) 
were observed clearly at 2 days following the MCAO/reperfusion 
surgery. In control rats, signal increase was found mainly in the 
cerebral cortex and striatum (caudate–putamen). In addition to 
the formation of cerebral edema, hemispheric brain swelling (the 
left hemisphere in the case of Figure 1A) was observed in the same 
animals. Oral administration of the high dose (2.0 g/kg) of lysine 
suppressed cerebral edema, especially in cerebral cortex (Figure 1B). 
Brain swelling was also ameliorated following lysine treatment.
The total volume of cerebral edema was evaluated by calculating 
the total number of voxels corresponding to the edematous site 
throughout all image slices (Figure 2). The effect of lysine was dose-
dependent [F(36,2) = 3.685, p < 0.05]. In the 2.0 g/kg lysine-treated 
group, total volume of cerebral edema was reduced significantly 
compared to the control group (251.6 ± 32.2 mm3 in the control 
group and 153.8 ± 23.0 mm3 in the 2.0 g/kg lysine-treated group, 
39% reduction, p < 0.05). Administration of 0.6 g/kg lysine alone 
(196.0 ± 32.5 mm3, 22% reduction, p = 0.15) or 0.6 g/kg arginine 
alone (178.4 ± 25.7 mm3, 29% reduction, p = 0.08) tended to reduce 
the cerebral edema. However, combination of 0.6 g/kg lysine and 
0.6 g/kg arginine (162.6 ± 21.0 mm3) showed significant reduction 
An eight-barreled glass micropipette assembly was used for 
microiontophoretic application of chemicals and an indwelling 
carbon fiber (7-μm diameter; Toray, Tokyo, Japan) protruding 
15–20 μm from the central barrel was used for neuronal record-
ing. The outer barrels were filled with monosodium l-glutamate 
(0.05 M, pH 8.5), l-lysine HCl (0.05 M, pH 6.0), l-arginine (0.05 M, 
pH 6.0), l-threonine (0.05 M, pH 8.5) and NaCl (0.15 M). The 
pH of amino acid solutions were adjusted as described above by 
0.1 N HCl or 0.1 N NaCl. Two barrels were filled with 4 M NaCl for 
current balancing. The chemicals were ejected pseudo-randomly 
using current strength of 10–90 nA of appropriate polarity and 
for the duration of 30–60 s by an microiontophoretic apparatus 
(DIA Medical System, Tokyo, Japan). Intertrial intervals of at least 
2 min were allowed for neurons recover from the effects of chemi-
cal. To exclude any artifacts (i.e., current effects), the null baseline 
neuronal responses to Na+ and Cl− by application of either plus or 
minus current on a NaCl barrel, respectively, were verified dur-
ing the initial trials. A neuronal response of more than 30% from 
the basal firing rate was considered as significant responses to the 
chemicals applied.
calculatIon of cerebral edeMa voluMe
Volume of cerebral edema was calculated as follows:
Edema volume = (number of voxels in edema region)  
         × (voxel volume),
where the voxel volume was 0.108 mm3 (0.3 mm × 0.3 mm × 1.2 mm). 
The criterion of voxels within the edema region was defined as 
voxels with hyperintensity of 20% relative to the corresponding 
anatomical structures in the contralateral hemisphere (Kondoh 
et al., 2002; Torii et al., 2004). Voxels that corresponded to the 
cerebroventricles were excluded carefully. The anterior–posterior 
position to bregma of each image was determined by a rat brain 
atlas (Paxinos and Watson, 1997).
calculatIon of heMIspherIc braIn swellIng
Because of limited space in the cranium, cerebral edema is generally 
accompanied by swelling of brain tissue and, hence, associates with 
increased intracranial pressure, which contributes significantly to 
the amount of neural tissue damaged.
Brain swelling of ischemic hemisphere, as noted by movement 
of mid-sagittal line to contralateral non-ischemic hemisphere, was 
determined on T2-weighted coronal MRI images at the level of 
bregma as follows:
% Swelling = ((area of ischemic hemisphere × 2/area of both left 
             and right hemispheres) − 1) × 100
Position of mid-sagittal line was determined manually with the 
aid of hypointense area between the left and right hemispheres 
(see Figure 1).
calculatIon of t2 values
T2 maps calculated from the multi-echo images were produced 
on the basis of pixel-by-pixel with the use of linear least-squares 
regression. Regions of interest for non-ischemic striatum and tem-
poral muscle were selected manually on T2 maps and then the value 
was averaged.Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 18  |  5
Kondoh et al.  Neuroprotection by lysine and arginine
FIgure 1 | examples of five consecutive coronal brain images of MCAO rats 
administrated with (A) saline or (B) lysine as measured by T2-weighted MrI. 
Brain areas with hyperintensity (i.e., increase in water content) was observed in the 
left hemispheres, which represent presence of edema. Note that oral administration 
of lysine (2.0 g/kg) suppressed cerebral edema, especially in the cerebral cortex. 
Lysine also reduced hemispheric brain swelling. Slice thickness, 1.2 mm.
FIgure 2 | reduction of whole cerebral edema volume by oral 
administration of lysine (Lys) and/or arginine (Arg) in MCAO rats. 
Administration of lysine alone at high dose (2.0 g/kg), or combined 
administration of lysine and arginine at low doses (0.6 g/kg each) significantly 
suppressed whole cerebral edema volume. Numbers between parentheses 
represent number of experiments. *p < 0.05, significance compared to 
saline-treated control groups by ANOVA followed by Fisher’s PLSD test.
FIgure 3 | effects of lysine (Lys) and/or arginine (Arg) on cortical and 
striatal edema in MCAO rats. Note that significant reduction of edema 
volume was observed in the cerebral cortex but not in the striatum by 
administration of lysine (2.0 g/kg), arginine (0.6 g/kg), or combined 
administration of lysine and arginine. *p < 0.05, significance compared to the 
saline-treated control group by ANOVA followed by Fisher’s PLSD test.
of cerebral edema by 35% compared to the control group (p < 0.05). 
No significant differences were detected among 0.6 g/kg lysine, 
0.6 g/kg arginine, and their combination groups.
The suppression of cerebral edema by oral administration of 
lysine or arginine was prevalent in the cerebral cortex (Figure 3). 
Administration of 2.0 g/kg lysine, 0.6 g/kg arginine, and a mixture 
of lysine and arginine resulted in significant reduction in cortical 
edema (p < 0.05), while no effect was observed on striatal edema 
in any amino acid groups. The protective effect of lysine on cortical 
edema was dose-dependent [F(36,2) = 4.758, p < 0.05]. There were 
no significant differences among 0.6 g/kg lysine, 0.6 g/kg arginine, 
and their combination groups.
To assess the effects of lysine and/or arginine with respect to the 
anteroposterior axis, extent of edema volume in each image slice 
(1.2-mm thickness) was calculated (Figure 4). In saline-treated 
controls, edema volume distributed across a wide area between + 6 
mm (anterior) to −7.2 mm (posterior), with a peak at −1.2 mm 
from bregma. Treatment of lysine or arginine appeared to reduce 
the edema volume across a large brain area, with a peak at 0 mm 
to bregma.Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 18  |  6
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and 0.6 g/kg arginine showed significant reductions of infarct areas 
compared to controls (p < 0.05). Administration of 0.6 g/kg lysine 
alone or 0.6 g/kg arginine alone tended to reduce infarct area. No 
significant differences were detected among 0.6 g/kg lysine, 0.6 g/
kg arginine, and their combination groups.
Infarct area measured by TTC staining was positively corre-
lated with cerebral edema measured by MRI (Y = 76.8 + 1.100X, 
r = 0.736, p < 0.0001) (Figure 7).
suppressIon of glutaMate-Induced actIvIty In the vMh
We investigated the effects of lysine and arginine on glutamate-
induced VMH neuronal activity in awake rats. Of a total of 25 
VMH neurons recorded, 11 (44%) neurons were inhibited by lysine 
and eight (32%) neurons were inhibited by arginine (Table 2). No 
neurons showed any response to microiontophoretic applications 
of threonine, Na+ and Cl−. The neuronal recording sites within the 
VMH were histologically confirmed.
Increases in tissue water content are known to associate with 
the increase in T2 relaxation time (T2 value). To exclude any non-
specific effects of amino acid themselves on MRI signal intensities 
of  non-ischemic  regions,  T2-weighted  multi-echo  images  were 
acquired with six echo times (20, 40, 60, 80, 100, and 120 ms). 
In the non-ischemic striatum and temporal muscle (an example 
of the extracerebral tissue), T2 values were approximately 70 and 
38 ms, respectively (Table 1). No amino acids altered T2 values in 
these non-ischemic regions (ANOVA, p > 0.05), suggesting that 
neither lysine nor arginine modified MRI signal intensities in a 
non-specific manner.
suppressIon of heMIspherIc braIn swellIng
Hemispheric brain swelling at the level of bregma was significantly 
reduced by administration of lysine and/or arginine compared 
with saline (Figure 5). Extents of swelling were 8.14 ± 1.16% 
in the saline group, 5.14 ± 0.81% in the 0.6 g/kg lysine group 
(p < 0.05), 3.60 ± 0.56% in the 2.0 g/kg lysine group (p < 0.01), 
4.36 ± 1.05% in the 0.6 g/kg arginine group (p < 0.01), and 
3.57 ± 0.71% in the combined administration of 0.6 g/kg lysine 
and 0.6 g/kg arginine (p < 0.01). The effect of lysine was dose-
dependent [F(36,2) = 6.845, p < 0.01]. No significant differences 
were detected among 0.6 g/kg lysine, 0.6 g/kg arginine, and their 
combination groups.
suppressIon of cerebral InfarctIon
2,3,5-Triphenyltetrazolium chloride-staining method applied to 
the treated brain slices (Figure 6) revealed that the neuroprotective 
effects of lysine or arginine on cerebral infarction appeared to be 
similar to those observed with MRI methods. The effect of lysine 
was dose-dependent [F(36,2) = 3.543, p < 0.05]. Administration of 
2.0 g/kg lysine alone or combined administration of 0.6 g/kg lysine 
FIgure 4 | rostrocaudal extension of cerebral edema. The value 0 
represents the bregma position in the antero-posterior axis, with more 
anterior parts represented by positive values and more posterior parts 
represented by negative values. Note that the extent of cerebral edema 
appeared to be reduced in overall levels by administration of lysine (Lys), 
arginine (Arg), or their combination.
Table 1 | T2 values in non-ischemic striatum and temporal muscle.
 T 2 values (ms)
Oral administration  Striatum  Temporal  n 
   muscle
Saline  69.0 ± 1.27  38.0 ± 0.98  12
Lysine (0.6 g/kg)  68.8 ± 0.84  38.6 ± 0.93  14
Lysine (2.0 g/kg)  71.6 ± 1.45  39.6 ± 0.88  13
Arginine (0.6 g/kg)  70.4 ± 1.07  37 .8 ± 0.69  11
Lysine (0.6 g/kg) + Arginine  71.7 ± 0.81  38.4 ± 0.67  14 
(0.6 g/kg)
The ‘n’ represents numbers of experiments.
FIgure 5 | reduction of hemispheric brain swelling by oral 
administration of lysine (Lys) and/or arginine (Arg) in MCAO rats. 
Administration of lysine alone (0.6 and 2.0 g/kg), arginine alone (0.6 g/kg), or 
combined administration of lysine and arginine at low doses (0.6 g/kg each) 
significantly suppressed hemispheric brain swelling. *p < 0.05 and **p < 0.01, 
significance compared to the saline-treated control group by ANOVA followed 
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FIgure 6 | reduction of infarct area by oral administration of lysine (Lys) 
and/or arginine (Arg) in MCAO rats. Infarct area was measured with TTC 
staining. Note that administration of lysine alone at high dose (2.0 g/kg) or 
combined administration of lysine and arginine at low dose (0.6 g/kg) 
significantly suppressed infarct in consistent to the effects on cerebral edema 
as shown in Figure 2. *p < 0.05, significance compared to the saline-treated 
control group by ANOVA followed by Fisher’s PLSD test.
FIgure 7 | Positive correlation between cerebral edema measured by 
MrI and infarct area measured by TTC staining in MCAO rats. Data from 
all experimental groups were combined for analysis. Y = 76.8 + 1.100X, 
r = 0.736, p < 0.0001.
Table 2 | responsiveness of VMH neurons to microiontophoretically 
applied chemicals in awake rats.
  Number of neurons
Chemicals  excitatory  Inhibitory  No response  Total
l-Lysine  0 (0%)  11 (44%)  14 (56%)  25 (100%)
l-Arginine  0 (0%)  8 (32%)  17 (68%)  25 (100%)
l-Threonine  0 (0%)  0 (0%)  13 (100%)  13 (100%)
Na+  0 (0%)  0 (0%)  25 (100%)  25 (100%)
Cl−  0 (0%)  0 (0%)  25 (100%)  25 (100%)
Numbers in parentheses denote the percentage of neurons observed in each 
response.
As shown in Figure 8, the neuron shows little firing activity before 
application of glutamate. The neuronal activity of 3–10 spikes/s 
was evoked after the continuous application of glutamate (−10 or 
−20 nA) to the neuron. Application of neither Na+ nor Cl− evoked 
measurable responses. When lysine or arginine (+50 to +70 nA) 
was applied to the neuronal membrane, glutamate-induced neu-
ronal activity was completely suppressed, typically within 300 ms. 
These inhibitory effects reversed gradually within 1–2 min, with 
activity increasing to preadministration levels after cessation of the 
application. Thus the inhibitory effects of lysine and arginine were 
reversible and reproducible. The inhibition by lysine appeared to 
persist for longer than by arginine.
dIscussIon
Strategies  for  reducing  cerebral  edema  in  the  early  phase  of 
ischemia play a fundamental role in the attempt to minimize sub-
sequent chronic neuronal damage in stroke. The present study 
has demonstrated, for the first time, that oral administrations 
of high dose of lysine alone (2.0 g/kg) or low dose of lysine and 
arginine in combination (0.6 g/kg each), are both effective against 
experimental ischemic damages (i.e., cerebral edema and infarc-
tion) in a rat model of MCAO/reperfusion. These amino acids 
robustly suppressed edema in cortex but failed to do so in striatum. 
Interestingly, administration of these basic amino acids, even at 
low dose (0.6 g/kg), significantly reduced hemispheric brain swell-
ing. Furthermore, both lysine and arginine suppressed glutamate-
evoked neuronal activity, which may contribute to the reduction of 
excitotoxicity caused by excess glutamate released into the synapse 
during ischemia.
The present study aimed at demonstrating potential benefi-
cial effects of lysine and arginine on ischemic insults. Since we 
expected moderate to weak effects of these amino acids by oral 
administration,  administrations  were  made  twice,  before  and 
during the ischemia. Therefore, we could not conclude whether 
the effects of lysine and arginine were prophylactic or therapeutic 
for ischemic cerebral damages. Further studies will be required to 
resolve this issue.
suppressIon of glutaMate-Induced neuronal actIvIty
Lysine and arginine are positively charged amino acids, while gluta-
mate is negatively charged. Both lysine and arginine completely 
blocked  glutamate-evoked  neuronal  excitation  in  microionto-
phoresis experiments, suggesting that lysine and arginine suppress 
glutamatergic neuronal activity in vivo and dietary levels of these 
amino acids might modulate brain activity via glutamatergic inhi-
bition. Glutamate activates ionotropic glutamate receptors, includ-
ing NMDA receptor that behaves as a single-occupancy channel 
for small monovalent and divalent permeant cations (Zarei and 
Dani, 1994). Considering the rapid onset of the suppressive effects, 
lysine/arginine might block directly the ion channels (open channel 
block) via mechanisms similar to those associated with Zn2+ and Mg2+ 
(Mayer et al., 1984; Nowak et al., 1984). Another possibility relates to 
indirect actions of lysine/arginine via activation of non-glutamate 
receptors or via adjacent inhibitory interneurons. For example, lysine 
interacts directly with a variety of receptors and can act both as an Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 18  |  8
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tryptophan. For example, melatonin decreases the area of cortical 
infarction by ∼60% and striatal infarction by 30% (Borlongan 
et al., 2000) and decreases the cortical edema volume by ∼60% and 
striatal edema by 34% (Torii et al., 2004). The differential altera-
tions of basic amino acids may be explained by the anatomical 
differences in blood vessel distribution, in which moderate but 
significant increases in bypass blood flow (collateral circulation) in 
the cerebral cortex compared with striatum. For example, arginine 
administration increases cerebral blood flow in ischemic condi-
tions (Dalkara et al., 1994; Sadoshima et al. 1997). Intravenous 
arginine infusions increase cerebral blood volume in the cortex but 
not in the striatum in non-ischemic rats (Caramia et al., 1998).
Alternatively, higher number of cortical astrocytes (White et al., 
1992) than striatal astrocytes (Bronstein et al., 1995) may account 
for better protection of the cortex than the striatum against ischemic 
insult. Astrocytes can exert protective actions on neural survival by 
releasing many neurotrophic factors, siphoning excess extracellular 
water and potassium ion, and reducing glutamate toxicity by remov-
ing glutamate from synapses (White et al., 1992; Ridet et al., 1997). 
Co-culture of astrocyte and neuron appear to promote higher levels 
partial antagonist of the serotonin receptor type 4 (Smriga and Torii, 
2003a) and as an agonist of benzodiazepine (Chang and Gao, 1995), 
calcium-sensing (Conigrave et al., 2000) and “GPRC6A” (G-protein-
coupled receptor, family C, group 6, subtype A; Wellendorph et al., 
2005) receptors. However, these mechanisms were less likely since 
microiontophoretically applied chemicals can act only within a very 
narrow area, possibly involving only the recorded neuron. Although 
it is premature to assign any particular function, our findings bring 
to light a functional interaction between basic amino acids and gluta-
mate in the brain. Suppression of glutamatergic neurons by lysine 
and arginine might contribute to the suppression of cerebral ischemic 
damages. Further studies are needed to clarify the mechanisms of 
these inhibitory actions and potential therapeutic interventions.
cerebral cortex vs. strIatuM
Cerebral edema and infarction were reduced significantly in the 
cerebral cortex, but not in the striatum, after treatment with lysine 
alone, or with a combination of lysine and arginine. These differ-
ential alterations have also been reported following oral adminis-
tration of melatonin, a pineal secretory product synthesized from 
FIgure 8 | An example of inhibitory responses to lysine and arginine 
applied microiontophoretically on glutamate-induced single unit activity 
in a rat VMH neuron. (A) The position of VMH in the rat brain. (B) A schematic 
representation of the multi-barreled glass micropipette with a recording 
electrode. (C) Suppression of glutamate-induced activity by lysine and 
arginine. Firing rate of this neuron was little at the basal level; therefore 
glutamate (−10 or −20 nA) was applied continuously in the background to 
evoke steady-state levels of firing activity. Microiontophoretic applications 
(45 s) of either lysine or arginine did inhibit this glutamate-induced neuronal 
activity whereas neither Na+ nor Cl− modified it. Lower trace was the 
continuous recording of the upper trace. Note that inhibitory responses by 
lysine and arginine occurred rapidly while the recovery of inhibitory responses 
occurred slowly for 1–2 min after cessation of the application. Numerical 
values under the chemicals represent current strength (nA) applied for ejection 
of each chemical from the tip of multi-barreled micropipettes. The similar 
responses were repeatedly observed in other neurons. Ordinate: Neuronal 
discharge rate/s. Abscissa: time. Bars: period of 
microiontophoretic applications.Frontiers in Integrative Neuroscience  www.frontiersin.org  June 2010  | Volume 4  | Article 18  |  9
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lysIne and neuroprotectIon
Although l-lysine shares many of the chemical properties of arginine 
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conclusIon
In summary, oral administration of high doses of lysine or combina-
tion of low dose of lysine with arginine is effective against cerebral 
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of transient focal ischemia. Lysine and arginine were effective neu-
roprotectors in the cerebral cortex, and were also effective to reduce 
hemispheric brain swelling. These amino acids also suppressed 
glutamate-evoked neuronal activity in vivo. These results suggest 
that daily ingestion of lysine and/or arginine might be beneficial to 
prevent cerebral ischemic injury.
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of neuronal survival compared to purely neuronal cultures (Ridet 
et al., 1997). Glial cells were more vulnerable than neurons against 
ischemia (Borlongan et al., 2000). These findings suggest that glial 
cells are critical to neuronal survival and hence lysine and arginine 
might enhance survival of both neuronal and glial cells.
argInIne and neuroprotectIon
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studied during the last 20 years by many researchers in terms of the 
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flow both in baseline (Morikawa et al., 1992; Sadoshima et al., 
1997; Caramia et al., 1998) and ischemic conditions (Dalkara et al., 
1994; Sadoshima et al. 1997). Recovery of cerebral blood flow for 
more than 30% is associated with signal reappearance in electro-
encephalograms (Dalkara et al., 1994). The d-form of arginine 
(Morikawa et al., 1992; Dalkara et al., 1994) and the non-selective 
smooth muscle relaxant papaverine (Zhang and Iadecola, 1994) 
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induced specifically by the l-form of arginine. Administration 
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and  Iadecola,  1994),  while  administration  of  NOS  inhibitors 
exacerbates ischemic damages (Kuluz et al., 1993). NO acts neu-
roprotector via S-nitrosylation of NMDA receptor thiol and sup-
pression of NMDA receptor activity in the presence of conditions 
leading to the synthesis of nitrosonium ion (NO+) (Satoh and 
Lipton, 2007).
In contrast to the protective effects mentioned above, different 
lines of evidence suggest that arginine exacerbates ischemic infarc-
tion (Zhao et al. 2003) and NOS inhibitors ameliorate it (Buisson 
et al., 1992; Kozniewska et al., 1995; Quast et al., 1995). One plau-
sible explanation for such discrepancy may be that the arginine 
effect depends on the redox state of the body (Lipton et al., 1993). 
For example, under conditions of preferential production of the 
NO radical (NO·), arginine is cytotoxic via production of toxic 
free radicals, such as peroxynitrite anion (ONOO−), which lead 
to indiscriminate damage to biological macromolecules includ-
ing DNA, proteins, and membrane lipids (Halliwell et al., 1992; 
Lewén et al., 2000). The redox versatility of NO may explain its 
interconversion from neuroprotective to neurotoxic species by a 
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